Regulating Antimicrobial Action: The EMA Approach
Focusing on combating multidrug resistance, R&D regulations and implementing public and private partnerships, SMi is proud to present their 15th annual conference on Superbugs and Superdrugs the only event of its kind in Europe.
London, UK (PRWEB UK) 18 January 2013
SMi is pleased to confirm Line Matthiesen, Head of Infectious Diseases and Public Health Unit, European Commission as a speaker at the upcoming event.
He will discuss meeting the challenges in implementing the European Commission's Action plan on antimicrobial resistance, partnerships with industry on antimicrobial resistance, partnerships among countries on antimicrobial resistance and the vision on future research under Horizon 2020.
Attending this event will enable delegates to hear:
Over 16 international speakers from top pharma companies, BARDA, top universities, The European Commission and EFPIA
Case study on mechanisms of action for inhibiting antibiotics
Unparalleled multi-disciplinary networking opportunities
Hot topic sessions on combating fungal infections and regulatory requirements for antimicrobial developers
A focus on the discovery and development of novel antiviral agents at Johnson & Johnson
For more information or to book your place visit http://www.smi-online.co.uk/goto/superbugssuperdrugs34.asp or contact Cem Tuna on +44 0 207 827 6736 or email ctuna(at)smi-online(dot)co(dot)uk.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebsuperbugs/antibacterial/prweb10325769.htmView Comments and Join the Discussion!